Prescribing pre-exposure prophylaxis in general practice.

Background: Pre-exposure prophylaxis (PrEP) is a highly effective method of human immunodeficiency virus (HIV) prevention available to prescribe on the Pharmaceutical Benefits Scheme general schedule.

Objective: The aim of this article is to provide information and guidance to general practitioners (GPs) and other healthcare providers on providing PrEP, and to discuss efficacy, adverse effects, monitoring and further resources.

Discussion: GPs can play a central role in discussing HIV prevention strategies for people who may be at risk of HIV.

Huge Abdominal Mass in a Young Unmarried Lady - A Social and Psychotherapeutic Challenge.

Large ovarian tumours are rare. Various diagnostic modalities are used to help in confirming the size and type of ovarian tumours. Laparotomy in a lateral decubitus position under general anaesthesia is the most common treatment approach.

Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent.

Background: The disproportionate intrauterine growth intervention trial at term was an intention to treat analysis and compared labor induction with expectant monitoring in pregnancies complicated by fetal growth restriction at term and showed equivalence for neonatal outcomes.

Objective: To evaluate trial participation bias and to examine the generalizability of the results of an obstetrical randomized trial.

Study Design: We used data from participants and nonparticipants of a randomized controlled trial-the disproportionate intrauterine growth intervention trial at term (n=1116) -to perform a secondary analysis.

Head and neck squamous cell carcinoma survivorship care.

Background: Head and neck cancer is the seventh most commonly diagnosed cancer in Australia. More than 90% of these cancers are squamous cell carcinomas (SCCs). With advances in cancer therapies, survivorship care is becoming increasingly topical.